Get my own profile
Public access
View all37 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Blank cNetherlands Cancer InstituteVerified email at nki.nl
- Ylstra BaukeVU University Medical CenterVerified email at vumc.nl
- Ton N.M. SchumacherThe Netherlands Cancer Institute, Third Rock VenturesVerified email at nki.nl
- Gerrit A Meijerprofessor of oncologic pathology, Netherlands Cancer Institute, University Medical Center UtrechtVerified email at nki.nl
- Ultan McDermottFaculty, Wellcome Trust Sanger InstituteVerified email at sanger.ac.uk
- Rene BernardsNetherlands Cancer InstituteVerified email at nki.nl
- Wilbert ZwartProfessor Functional Genomics in Oncology, Groupleader, The Netherlands Cancer InstituteVerified email at nki.nl
- Lodewyk WesselsProfessor of Computational Cancer BiologyVerified email at nki.nl
- Ekaterina NevedomskayaScientist, Bayer AGVerified email at bayer.com
- van de Wiel MAVerified email at vumc.nl
- Hugo M. HorlingsMD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsVerified email at nki.nl
- Sabine LinnProfessor of Translational Oncology - Utrecht University; Group leader NKI AmsterdamVerified email at nki.nl
- Daoud SieHuman Genetics, Amsterdam UMCVerified email at amsterdamumc.nl
- Paul RoepmanHartwig Medical FoundationVerified email at hartwigmedicalfoundation.nl
- Remond J.A. FijnemanNetherlands Cancer Institute, Amsterdam, The NetherlandsVerified email at nki.nl
- J Bueno-de-MesquitaAntes / SprinkVerified email at sprink.nl
- Robert van BoerdonkPhD, VU University Medical Center, AmsterdamVerified email at vumc.nl
- Kristian UngerLMU University HospitalVerified email at med.uni-muenchen.de
- Annuska M GlasQuantum Leap Healthcare Collaboration
- Ron M. KerkhovenRetired Associated Scientist, Netherlands Cancer Institute